Featured Content
Eric Palmer, executive vice president of enterprise strategy for the Cigna Group, will exit the company April 26. Mr. Palmer,…
CMS has suspended enrollment for two Medicare Advantage prescription drug…
UnitedHealth Group is feeling “better than pretty good” about the…
Patient expectations will push healthcare to evolve by 2030, according…
Becker’s offerings
Upcoming Events & Conferences
The Latest
Eric Palmer, executive vice president of enterprise strategy for the Cigna Group, will exit the company April 26. Mr. Palmer, who also served as CEO of Evernorth Health Services, will receive a $5.2 million cash payment upon his exit, according…
CMS has suspended enrollment for two Medicare Advantage prescription drug plans offered by eternalHealth, a Boston-based insurer. In March, Massachusetts regulators banned eternalHealth from marketing any of its products and services in the state and suspended new member agreements until…
Texas lawmakers are urging further action against Superior Health Plan, after the plan’s former CEO admitted to using private investigators to research lawmakers. In an April 10 letter, the members of Texas House Committee on Delivering on Government Efficiency requested…
Five Blue Cross Blue Shield plans will require prior approval for certain severe asthma medications when administered in a healthcare setting, as part of a broader update to its medical policies for self-administered drugs. The change includes four injectibles commonly…
The executive vice president of an insurance brokerage firm pleaded guilty to his role in a scheme to submit fraudulent applications to enroll individuals in ACA plans. The purpose of the scheme was to obtain millions of dollars in commission…
Humana’s board of directors declared a $0.885 per share dividend to be paid July 25. The dividend will be paid to all shareholders of record as of the close of business June 27, according to an April 17 Humana news…
UnitedHealth Group’s “unusual and unacceptable” first-quarter results have led the company’s top executives to change their tone regarding CMS’ Medicare Advantage V28 risk adjustment model. The V28 model is a phased-in change that began in 2024 and will continue through…
Blue Cross Blue Shield of Massachusetts will no longer cover GLP-1 drugs for weight loss as part of its standard benefits, the Boston Globe reported April 17. In a statement shared with Becker’s, a BCBS Massachusetts spokesperson said the company…
Elevance Health is reaffirming that shareholders’ adjusted net income guidance for full year 2025 will be $34.15 to $34.85 per diluted share. The company said in an April 17 regulatory filing that its first quarter results will reflect medical cost…
UnitedHealth Group is feeling “better than pretty good” about the potential for pharmaceutical tariffs and the resulting possible impact on its businesses. President Donald Trump has threatened tariffs on pharmaceutical imports, with U.S. Commerce Secretary Howard Lutnick saying April 13…